Connect with us

Health

Monoclonal antibody neutralizes all SARS-CoV-2 variants of concern – News-Medical.Net

Researchers in Canada and the United States have identified a monoclonal antibody that potently neutralizes variants of severe acute respiratory syndrome coronavirus…

Published

on

Article feature image

Researchers in Canada and the United States have identified a monoclonal antibody that potently neutralizes variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the ongoing coronavirus disease 2019 (COVIdD-19) pandemic.
“LY-CoV1404 is a potent SARS-CoV-2-binding antibody that neutralizes all known variants of concern,” says Bryan Barnhar from AbCellera Biologics Inc. in Vancouver and colleagues.
The researchers warn that new variant-resistant treatments…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

There’s No Hidden U.S. Vaccine Stockpile Ready to Send Abroad – Financial Post
Covid-19: France’s vaccine rollout on track to hit 20 million target – Yahoo Eurosport UK